XPH logo

XPH Overview

Profile

Name:

SPDR S&P Pharmaceuticals ETF

Assets under management:

$164 M

Expense ratio:

0.35%

Inception date:

June 19, 2006

Last ex-dividend date:

December 23, 2024

Next ex-dividend date:

N/A

Description:

The XPH ETF, or SPDR S&P Pharmaceuticals ETF, focuses on investing in U.S. pharmaceutical companies. It aims to track the performance of the S&P Pharmaceuticals Select Industry Index, providing exposure to the pharmaceutical sector, including major drug manufacturers and biotech firms.

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Technical Analysis

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend per share

Dividend yield

Analyst ratings

FAQ

  • What is XPH?
  • Does XPH pay dividends?
  • What stocks are in XPH?
  • What is the current assets under management for XPH?
  • What is XPH average volume?
  • What is XPH expense ratio?
  • What is XPH inception date?

What is XPH?

The XPH ETF, or SPDR S&P Pharmaceuticals ETF, focuses on investing in U.S. pharmaceutical companies. It aims to track the performance of the S&P Pharmaceuticals Select Industry Index, providing exposure to the pharmaceutical sector, including major drug manufacturers and biotech firms.

Does XPH pay dividends?

Yes, the SPDR S&P Pharmaceuticals ETF does pays dividends, with the most recent payment being $0.15 per share. The last ex-dividend date was on December 23, 2024, and the next ex-dividend date has not been announced yet

What stocks are in XPH?

As of today, SPDR S&P Pharmaceuticals ETF inlcudes 46 holdings, with 45 of them being companies from 2 different countries and 1 sectors. The most weighted holdings are Intra-Cellular Therapies (5.42%), Axsome Therapeutics (4.98%) and Royalty Pharma (4.69%)

What is the current assets under management for XPH?

Assets under management of SPDR S&P Pharmaceuticals ETF is $164 M

What is XPH average volume?

Average volume of SPDR S&P Pharmaceuticals ETF is $54 K

What is XPH expense ratio?

Expense ratio of SPDR S&P Pharmaceuticals ETF is 0.35%

What is XPH inception date?

Inception date of SPDR S&P Pharmaceuticals ETF is June 19, 2006